Document is current
Any future updates will be listed below
-
Authors
Bakker, N. F. https://orcid.org/0000-0001-9203-9348
Knoop, J. https://orcid.org/0000-0002-2464-9037
van den Hout, W. B. https://orcid.org/0000-0002-6425-0135
Hutting, N. https://orcid.org/0000-0002-6164-6265
Engels, J. A. https://orcid.org/0000-0003-3292-4702
Staal, J. B. https://orcid.org/0000-0002-0083-6380
van der Leeden, M. https://orcid.org/0000-0001-6465-0983
Boonen, A. https://orcid.org/0000-0003-0682-9533
Willemze, A. https://orcid.org/0009-0009-5680-8782
Nurmohamed, M. T. https://orcid.org/0000-0002-6274-1934
Vliet Vlieland, T. P. M. https://orcid.org/0000-0001-6322-3859
Gademan, M. G. J. https://orcid.org/0000-0002-6106-3385
van Weely, S. F. E. https://orcid.org/0000-0001-8560-4687
-
Funding
Funding for this research was provided by:
Dutch Arthritis Society (2019-09-01)
Koninklijk Nederlands Genootschap voor Fysiotherapie (2019-09-01)
- License Information
-
More Information
Article History
Received: 31 July 2025
Accepted: 16 October 2025
First Online: 15 December 2025
Declarations
:
: N.F. Bakker, J. Knoop, W. B. van den Hout, N. Hutting, J.A. Engels, J.B. Staal, M. van der Leeden, A. Willemze, M.T. Nurmohamed, T.P.M. Vliet Vlieland, M.G.J. Gademan and S.F.E. van Weely declare that they have no conflict of interest. A. Boonen received research grants from Abbvie and Lilly, and honoraria for lectures or consultation from Pfizer, Novartis, UCB, Abbvie and Galapagos; all to her department.
: to conduct the study was obtained on the 22th of July 2021 from the Medical Ethics Committee Leiden The Hague Delft (P21.050). This study was conducted in agreement with the declaration of Helsinki and in compliance with the General Data Protection Regulations and the Dutch Medical Research Involving Human Subjects Act. All participants provided written informed consent for their participation. The study protocol was included in the International Clinical Trial Registry Platform (ICTRP) under number NL-OMON26117 (ICTRP Search Portal).
: This article is published under an open access license and is freely available to the public. Readers are permitted to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author, provided proper citation is given.
: This study was selected by the European Alliance of Associations for Rheumatology (EULAR) Congress 2025 (11–14 June) for an oral abstract presentation. The congress abstract was online published by EULAR: Bakker NF, van Weely SFE, Hutting N, Heerkens YF, Engels JA, Staal JB, van der Leeden M, Boonen A, van den Hout WB, Vliet Vlieland TPM, Knoop J. Effectiveness and cost-effectiveness of a multimodal, physiotherapist-led, vocational intervention in people with inflammatory arthritis: study protocol of the Physiotherapy WORKs trial. BMC Rheumatol. 2023 Sep 20;7(1):31. doi: .
